Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelia

376Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

A new monoclonal antibody, Ber-EP4, directed against a partially formol resistant epitope on the protein moiety of two 34 kilodalton and 39 kilodalton glycopolypeptides on human epithelial cells is described. Immunostaining of a wide range of normal and neoplastic human tissues and cell lines showed that all carcinomas and all non-neoplastic epithelial cells, except hepatocytes, parietal cells, and apical cell layers in squamous epithelia, homogeneously expressed Ber-EP4 antigen. As Ber-EP4 does not detect any normal or neoplastic non-epithelial cells, this antibody might prove valuable for the differentiation of the following (i) non-epithelial tumours from undifferentiated carcinomas; (ii) hepatocytes from bile duct cells in certain liver diseases; (iii) mesothelial cells from carcinoma cells in lung biopsy specimens; and (iv) reactive mesothelial cells from carcinoma cells in smears of serous effusions.

Cite

CITATION STYLE

APA

Latza, U., Niedobitek, G., Schwarting, R., Nekarda, H., & Stein, H. (1990). Ber-EP4: New monoclonal antibody which distinguishes epithelia from mesothelia. Journal of Clinical Pathology, 43(3), 213–219. https://doi.org/10.1136/jcp.43.3.213

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free